You are here

Healthwise and Tencent Announce Partnership

BOISE, Idaho, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Healthwise and Tencent announced today they will partner in offering award-winning health content from Healthwise to China’s population. 

Healthwise President and CEO Bob Kyte expressed, “We are excited to have this opportunity with our colleagues at Tencent. This is an extraordinary time for us to extend the Healthwise mission to help people make better health decisions around the world.” Healthwise content is widely used across the U.S. and Canada—this will be the first time it’s offered in China.

People in China will have easy access to evidence-based, consumer-friendly information on thousands of health topics, covering what people want to know—from preparing for medical tests or procedures to learning how to manage ongoing health concerns to living a healthy lifestyle. Tencent will translate and localize the Healthwise content for their users.

Meng Zhang, General Manager of Tencent Healthcare Information Center, says about the partnership, “We want to offer our users a reliable source of health information—unbiased, scientifically based information that is consumer-friendly. We were looking for the best health information in the world. And that is Healthwise.” Access to Healthwise content will benefit over 1.3 billion people in China.

Tencent, a leader in Internet technology, is headquartered in Shenzhen, China. More than two-thirds of China’s population use Tencent’s two messaging apps, Weixin and QQ. Tencent’s social products link users to a rich digital content catalogue.

About Healthwise
Healthwise is a nonprofit organization with a mission to help people make better health decisions. People have turned to Healthwise information 2 billion times to learn how to do more for themselves, ask for the care they need, and say “no” to the care they don’t need. Healthwise partners with hospitals, electronic medical record (EMR) providers, health plans, care management companies, and health websites to provide up-to-date, evidence-based information to the people they serve. 1.800.706.9646

Media Contact:
Sonja Deines
Phone: 208.489.8481

Tuesday, October 17, 2017 - 08:00

More Headlines

New Algorithm Surveys Alterations in DNA and Millions of Points in the Human Genome
First Oral Drug Increases Activity of the Body’s Deficient Enzyme
Venous Thromboembolism and Other Risks to Be Evaluated in Postmarketing Studies
Researchers Recommend Increased Testing for Men
New Draft Guidance Seeks to Better Target Patient Needs
It’s All in How the Data Are Analyzed
Two Phase 3 Studies Met Endpoint of Complete Clearance of Lesions